Announced details
Functional food ingredients, processed marine products, processed soy products, processed agricultural products, high-value-added products, and B2B and B2C sales channels
An investment partnership managed by 大和PIパートナーズ has entered into an agreement to transfer all shares in 株式会社マリン・プロフーズ to Pharma Foods International Co.,Ltd. 大和PIパートナーズ is indirectly 100% owned by 大和証券グループ本社 through 大和インベストメントマネジメント.
Date established: 12 September 1997; representative: Representative Director and President Kim Moo-jo (金武祚); head office: 1-49 Misasagi Ohara, Nishikyo-ku, Kyoto; business activities: development and sale of functional food ingredients, mail-order business, and biomedical business
Transfer price undisclosed
The company does not address Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Counterparty | Pharma Foods International Co.,Ltd. (securities code: 2929) |
| Counterparty overview | Date established: 12 September 1997; representative: Representative Director and President Kim Moo-jo (金武祚); head office: 1-49 Misasagi Ohara, Nishikyo-ku, Kyoto; business activities: development and sale of functional food ingredients, mail-order business, and biomedical business |
| Relationship with the Company | An investment partnership managed by 大和PIパートナーズ has entered into an agreement to transfer all shares in 株式会社マリン・プロフーズ to Pharma Foods International Co.,Ltd. 大和PIパートナーズ is indirectly 100% owned by 大和証券グループ本社 through 大和インベストメントマネジメント. |
| Contract Value | Transfer price undisclosed |
| Contract Date | 6 October 2026 |
| Applicable area | Functional food ingredients, processed marine products, processed soy products, processed agricultural products, high-value-added products, and B2B and B2C sales channels |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The parties believe that 株式会社マリン・プロフーズ can achieve further growth under Pharma Foods International Co.,Ltd.’s business platform. Synergies are also expected through the mutual utilisation of the two companies’ functional food ingredients, research and development capabilities, product development capabilities and customer bases, including the development of high-value-added products and the expansion of sales channels.